MARKETS
Earnings

Amazon, Eli Lilly On Deck Thursday As AWS Growth, Drug Demand Face Test

Oct 28, 2026 · 03:30 PM ET· updated 1h ago
Amazon, Eli Lilly On Deck Thursday As AWS Growth, Drug Demand Face Test

Amazon headlines Thursday’s reports, with investors focused on whether accelerating AWS growth and heavy AI spending can support the next leg of its expansion. Eli Lilly, Mastercard, Merck, Caterpillar and Shell report

Share
Why It Matters

Amazon and Eli Lilly are reporting their results Thursday. Watch whether Amazon's cloud business is growing fast enough to pay for its AI investments, and whether Eli Lilly's drug sales stay strong.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.